InvestorQ : InvestorQ-Ask,Answer & Share All About Finance!
Rutuja Nigam made post

How are the COVID trials of Zydus Cadila progressing?

Answer
user profile image
Arti Chavan answered.
3 weeks ago


Zydus Cadila will complete late-stage trials for Coronavirus vaccine by Feb-Mar 2021. It plans to produce 100 million doses a year. Cadilla admitted that early human trials had been satisfactory. Permission for Phase 3 trials will only be sought after results of Phase 1 and 2. Cadila will also produce Remdesivir to treat COVID-19 patients as licensed by Gilead.